Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Senegal

Senegal: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.4% in 2024. ▼ Falling

Latest (2024)
0.4%
Change on year
down 20.0%
World rank
59th
of 215 countries
All-time high
0.9%
in 2015
All-time low
0.4%
in 2024
Years of data
10
2015–2024

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Senegal, 2015–2024

00.20.40.60.812015201920242015: 0.92016: 0.92017: 0.82018: 0.82019: 0.72020: 0.62021: 0.52022: 0.52023: 0.52024: 0.4

Source: United Nations Statistics Division, SDG Global Database.

Analysis

The most recent figure for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Senegal is 0.4%, measured in 2024. That is the lowest value across all 10 years on record.

Compared with earlier readings it is down 20.0% on the previous year and down 55.6% over ten years.

Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Senegal peaked at 0.9% in 2015 and was at its lowest, 0.4%, in 2024.

That places Senegal 59th out of 215 countries with data for 2024, putting it in the middle of the range.

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Senegal, year by year

Annual values for Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%) in Senegal, 2015 to 2024.
Year Value Change
2015 0.9%
2016 0.9% +0.0%
2017 0.8% -11.1%
2018 0.8% +0.0%
2019 0.7% -12.5%
2020 0.6% -14.3%
2021 0.5% -16.7%
2022 0.5% +0.0%
2023 0.5% +0.0%
2024 0.4% -20.0%

Averages by decade

DecadeAverage LowestHighest Years
2010s 0.8% 0.7% 0.9% 5
2020s 0.5% 0.4% 0.6% 5

Countries ranked near Senegal

  1. 56 Cyprus 0.5% compare
  2. 56 Eritrea 0.5% compare
  3. 56 Yemen 0.5% compare
  4. 59 American Samoa 0.4% compare
  5. 59 Bangladesh 0.4% compare
  6. 59 Burundi 0.4% compare
  7. 59 Cambodia 0.4% compare
  8. 59 Iraq 0.4% compare
  9. 59 Samoa 0.4% compare
  10. 59 Zambia 0.4% compare

See the full ranking of 236 places →

More development goals data for Senegal

All data for Senegal →

Frequently asked questions

What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Senegal?
Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Senegal was 0.4% in 2024, according to United Nations Statistics Division, SDG Global Database.
What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Senegal?
The highest recorded value was 0.9% in 2015.
What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Senegal?
The lowest recorded value was 0.4% in 2024.
How does Senegal rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
Senegal ranks 59th out of 215 countries with data for 2024.
Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Senegal?
Over the last ten years it is down 55.6%. The long-run trend across the full record is falling.
Where does this Senegal data come from?
The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).

Share, cite or embed this page

Cite this page

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Senegal. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 26 August 2026, from https://development-goals.statizoid.com/stat/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/senegal/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/stat/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/senegal/">Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Senegal</a> — Statizoid

About this data

Indicator
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%)
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
236 places, 2,360 data points, 2015–2024
Last refreshed